BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6589765)

  • 21. The therapy for infective endocarditis.
    Ramphal R; Shands JW
    Cardiovasc Clin; 1984; 14(3):285-98. PubMed ID: 6722856
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental animal endocarditis.
    Wright AJ; Wilson WR
    Mayo Clin Proc; 1982 Jan; 57(1):10-4. PubMed ID: 7054619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic therapy of infectious endocarditis (when, with what drug, how long?].
    Schuler G
    Z Kardiol; 1994 Jan; 83(1):2-8. PubMed ID: 8147065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocarditis: an overview.
    Barry J; Gump DW
    Heart Lung; 1982; 11(2):138-45. PubMed ID: 7037688
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
    Working P
    Heart; 1998 Feb; 79(2):207-10. PubMed ID: 9538323
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current trends in antimicrobial therapy of infective endocarditis.
    Brown JW; McKnight GT
    J La State Med Soc; 1980 Apr; 132(4):58-62. PubMed ID: 6989939
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of Staphylococcus aureus endocarditis and septicemia].
    Frimodt-Møller N; Espersen F; Thomsen VF
    Ugeskr Laeger; 1984 Nov; 146(45):3431-4. PubMed ID: 6515969
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.
    Rose WE; Rybak MJ; Kaatz GW
    J Antimicrob Chemother; 2007 Aug; 60(2):334-40. PubMed ID: 17540670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRSA endocarditis--postcardiac surgery.
    Wiper AJ; Schmitt M; Schofield I; Roberts DH
    Eur J Echocardiogr; 2006 Oct; 7(5):405-6. PubMed ID: 16950081
    [No Abstract]   [Full Text] [Related]  

  • 33. [Staphylococcal endocarditis: valve prostheses and pacemakers].
    Pachón Díaz J; de Alarcón González A
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():33-7. PubMed ID: 9441321
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcal bacteremia and endocarditis: state of the art.
    Bayer AS
    Arch Intern Med; 1982 Jun; 142(6):1169-77. PubMed ID: 6807232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK; Yeaman MR; Bayer AS
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of bacterial endocarditis].
    Halawa B
    Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
    [No Abstract]   [Full Text] [Related]  

  • 38. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
    Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
    Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies in experimental staphylococcal endocarditis in dogs. VI. Treatment with lysostaphin.
    Goldberg LM; DeFranco JM; Watanakunakorn C; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1967; 7():45-53. PubMed ID: 5628090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.